Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Endocrine Therapy”

260 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 260 results

Testing effectiveness (Phase 2)Looking for participantsNCT06587061
What this trial is testing

HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469956
What this trial is testing

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07033819
What this trial is testing

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

Who this might be right for
Ovarian Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07415525
What this trial is testing

IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerBorderline Resectable Pancreatic Adenocarcinoma
Zhejiang University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06361940
What this trial is testing

Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 100
Testing effectiveness (Phase 2)Ended earlyNCT06964165
What this trial is testing

A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)

Who this might be right for
Ovarian Neoplasms
Tesaro, Inc. 36
Testing effectiveness (Phase 2)Ended earlyNCT00889187
What this trial is testing

Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05605535
What this trial is testing

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasm EpithelialOvarian CancerFallopian Tube Neoplasms+2 more
CanariaBio Inc. 88
Testing effectiveness (Phase 2)UnknownNCT01372735
What this trial is testing

Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University Hospital Heidelberg 46
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Testing effectiveness (Phase 2)WithdrawnNCT02850874
What this trial is testing

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsPancreatic Adenocarcinoma
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Looking for participantsNCT07043270
What this trial is testing

24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC

Who this might be right for
Pancreas Adenocarcinoma
Dartmouth-Hitchcock Medical Center 35
Very early researchActive Not RecruitingNCT05415709
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous Adenocarcinoma+30 more
Ohio State University Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT02481635
What this trial is testing

Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University Health Network, Toronto 11
Testing effectiveness (Phase 2)Study completedNCT00530868
What this trial is testing

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

Who this might be right for
Breast CancerCancer of the BreastBreast Neoplasm
University of Alabama at Birmingham 75
Early research (Phase 1)Study completedNCT00588003
What this trial is testing

Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 45
Not applicableStudy completedNCT01442974
What this trial is testing

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Grupo Hospital de Madrid 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05069038
What this trial is testing

Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy

Who this might be right for
Breast Cancer
University of Nebraska 51
Large-scale testing (Phase 3)Study completedNCT01864746
What this trial is testing

Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery

Who this might be right for
Breast CancerHormonreceptor PositiveHer2-normal+2 more
GBG Forschungs GmbH 1,250
Next Page